# FDA Inspection 787299 - American National Red Cross - June 20, 2012

Source: https://www.keypedia.com/records/fda_inspections/american-national-red-cross/ab5d2161-4834-43d9-bc60-543867c6c0d7
Source feed: FDA_Inspections

> FDA Inspection 787299 for American National Red Cross on June 20, 2012. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 787299
- Company Name: American National Red Cross
- Inspection Date: 2012-06-20
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 859901 - 2013-12-20](https://www.keypedia.com/records/fda_inspections/american-national-red-cross/980509f9-f8b2-4a4d-b910-ed5caa136b7a)
- [FDA Inspection 664160 - 2010-05-12](https://www.keypedia.com/records/fda_inspections/american-national-red-cross/2e454206-6052-40ce-9bc8-ff6e0b5275bc)

Company: https://www.keypedia.com/companies/american-national-red-cross/f57d81a6-57ec-41a9-a869-0fd19dcdbb42

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d